BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14742528)

  • 1. Identification and cloning of immunodominant antigens of Coxiella burnetii.
    Zhang G; Kiss K; Seshadri R; Hendrix LR; Samuel JE
    Infect Immun; 2004 Feb; 72(2):844-52. PubMed ID: 14742528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I.
    Zhang GQ; Samuel JE
    Ann N Y Acad Sci; 2003 Jun; 990():510-20. PubMed ID: 12860683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.
    Zhang G; To H; Russell KE; Hendrix LR; Yamaguchi T; Fukushi H; Hirai K; Samuel JE
    Infect Immun; 2005 Mar; 73(3):1561-7. PubMed ID: 15731054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray.
    Beare PA; Chen C; Bouman T; Pablo J; Unal B; Cockrell DC; Brown WC; Barbian KD; Porcella SF; Samuel JE; Felgner PL; Heinzen RA
    Clin Vaccine Immunol; 2008 Dec; 15(12):1771-9. PubMed ID: 18845831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.
    Xiong X; Jiao J; Gregory AE; Wang P; Bi Y; Wang X; Jiang Y; Wen B; Portnoy DA; Samuel JE; Chen C
    J Infect Dis; 2017 May; 215(10):1580-1589. PubMed ID: 27703037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major Histocompatibility Complex Class II-Restricted, CD4
    Ledbetter L; Cherla R; Chambers C; Zhang Y; Mitchell WJ; Zhang G
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31792078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
    Chen C; van Schaik EJ; Gregory AE; Vigil A; Felgner PL; Hendrix LR; Faris R; Samuel JE
    J Infect Dis; 2019 Jul; 220(4):624-634. PubMed ID: 30938819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever.
    Williams JC; Hoover TA; Waag DM; Banerjee-Bhatnagar N; Bolt CR; Scott GH
    Ann N Y Acad Sci; 1990; 590():370-80. PubMed ID: 2378463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.
    Deringer JR; Chen C; Samuel JE; Brown WC
    Microbiology (Reading); 2011 Feb; 157(Pt 2):526-542. PubMed ID: 21030434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.
    Ledbetter L; Cherla R; Chambers C; Zhang Y; Zhang G
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427447
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice.
    Zhang G; Russell-Lodrigue KE; Andoh M; Zhang Y; Hendrix LR; Samuel JE
    J Immunol; 2007 Dec; 179(12):8372-80. PubMed ID: 18056383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and cloning of a 27-kDa Coxiella burnetii immunoreactive protein.
    Hendrix LR; Samuel JE; Mallavia LP
    Ann N Y Acad Sci; 1990; 590():534-40. PubMed ID: 2378476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein array of Coxiella burnetii probed with Q fever sera.
    Wang X; Xiong X; Graves S; Stenos J; Wen B
    Sci China Life Sci; 2013 May; 56(5):453-9. PubMed ID: 23633077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses.
    Chen C; Dow C; Wang P; Sidney J; Read A; Harmsen A; Samuel JE; Peters B
    PLoS One; 2011 Mar; 6(3):e17712. PubMed ID: 21423609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG.
    Zhang G; Peng Y; Schoenlaub L; Elliott A; Mitchell W; Zhang Y
    Infect Immun; 2013 Jun; 81(6):2112-22. PubMed ID: 23545296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Feasibility of Using
    Kumaresan V; Alam S; Zhang Y; Zhang G
    Front Immunol; 2021; 12():754690. PubMed ID: 34795669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term immune responses to Coxiella burnetii after vaccination.
    Kersh GJ; Fitzpatrick KA; Self JS; Biggerstaff BJ; Massung RF
    Clin Vaccine Immunol; 2013 Feb; 20(2):129-33. PubMed ID: 23192629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome and antigen profiling of Coxiella burnetii developmental forms.
    Coleman SA; Fischer ER; Cockrell DC; Voth DE; Howe D; Mead DJ; Samuel JE; Heinzen RA
    Infect Immun; 2007 Jan; 75(1):290-8. PubMed ID: 17088354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential serodiagnostic markers for Q fever identified in Coxiella burnetii by immunoproteomic and protein microarray approaches.
    Xiong X; Wang X; Wen B; Graves S; Stenos J
    BMC Microbiol; 2012 Mar; 12():35. PubMed ID: 22420424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational design of a novel multi-epitope vaccine against Coxiella burnetii.
    Jaydari A; Nazifi N; Forouharmehr A
    Hum Immunol; 2020; 81(10-11):596-605. PubMed ID: 32718721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.